Search

Search Results

• 

  COVID-19 pandemic and biological therapy in rheumatologic disorders: how to deal with?

  Z. Ahmadinejad, R. Assari, N. Ayoobi Yazdi, S.-H. Mazloomi, P. Javanshayani, H. Khalili Afousi, V. Ziaee

  173-177

  19-11-2020

  Published: 19 November 2020

  1573

  PDF: 977

• Study on the possible role of the -174G>C IL-6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritis

  M. Fabris, L. Quartuccio, S. Lombardi, M. Benucci, M. Manfredi, M. Saracco, F. Atzeni, P. Morassi, M.A. Cimmino, E. Pontarini, C. Fabro, R. Pellerito, P. Sarzi-Puttini, M. Cutolo, A. Carletto, L.M. Bambara, F. Fischetti, F. Curcio, E. Tonutti, S. De VIta

  253-258

  Published:

  2044

  PDF: 814

• The role of anti-nucleosome antibodies in systemic lupus erythematosus. Results of a study of patients with systemic lupus erythematosus and other connective tissue diseases

  P. Quattrocchi, A. Barrile, D. Bonanno, L. Giannetto, M. Patafi, V. Tigano, B. Ferlazzo

  109-113

  Published:

  962

  PDF: 3776
• 

  Is CDAI comparable to DAS 28 and SDAI regarding inter-observer agreement and correlation to MHAQ in Egyptian RA patients?

  K. El-Hadidi, S.M. Gamal, S. Saad, N.Y. Elsaid

  203-208

  28-01-2020

  Published: 28 January 2020

  1784

  PDF: 811

• Do we have markers to define the cardiovascular risk in rheumatoid arthritis patients?

  F. Atzeni, P. Sarzi-Puttini

  1-3

  Published:

  1494

  PDF: 690
• 

  Can restless legs be a sign of something else? A case report of spondyloarthritis presenting with restless legs syndrome and a review of the literature

  E. Yılmaz

  19-12-2023

  Published: 19 December 2023

  1859

  PDF: 540

• New classification criteria for rheumatoid arthritis

  C.A. Scirè, R. Caproali

  159-162

  Published:

  1993

  PDF: 8931

• Migraine in SLE: role of antiphospholipid antibodies and Raynaud’s phenomenon

  Virginia Annese, Paola Tomietto, Paolo Venturini, Serena D'Agostini, Gianfranco Ferraccioli

  50-58

  Published:

  841

  PDF: 1963
• 

  Comment to: Disseminated cutaneous herpes simplex, COVID-19 vaccination and rheumatoid arthritis patient: a case report and review

  B. Joob, V. Wiwanitkit

  29-12-2022

  Published: 29 December 2022

  716

  PDF: 301

• Rheumatic diseases at the court of the Medici of Florence: the so-called “gout” of the Medici

  G. Fornaciari, V. Giuffra

  229-237

  Published:

  1032

  PDF: 786

• Alexithymia and immunoendocrine parameters in patients affected by systemic lupus erythematosus and rheumatoid arthritis

  M. Vadacca, R. Bruni, F. Caccipaglia, F. Serino, L. Arcarese, F. Buzzulini, G. Coppolino, A. Rigon, N. Terminio, A. Afeltra

  50-56

  Published:

  1873

  PDF: 1052

• A comparison between the Simplified Disease Activity Index (SDAI) and the Disease Activity Score (DAS28) as measure of response to treatment in patients undergoing different therapeutic regimens

  Giovanna Cuomo, Gabriella Molinaro, Giovanni La Montagna, Sergio Migliaresi, Gabriele Valentini

  22-25

  Published:

  1501

  PDF: 1959
• 

  The clinical manifestations at the onset of antisynthetase syndrome: A chameleon with multiple faces

  A.C.C.D. Baccaro, G.L. Behrens Pinto, R.C.S. Carboni, S.K. Shinjo

  86-92

  23-07-2020

  Published: 23 July 2020

  1398

  PDF: 775

• Italian consensus on the recommendations about the use of methotrexate for the treatment of rheumatic diseases with a focus on rheumatoid arthritis: results from the “3E initiative”

  F. De Leonardis, S. Aliverini, E. Bonacci, A.M. Buono, S. Bombardieri, G.F. Ferraccioli, C. Montecucco, L. Sinigaglia, F. Trotta, G. Valentini

  34-45

  Published:

  1988

  PDF: 2223

• Effects of TNF antagonists on immune and neuroendocrine system

  G. Valesini, M. Cutolo

  3-7

  Published:

  1139

  PDF: 725
• 

  Poncet’s disease diagnostic criteria decodes conundrum: Poncet’s vs pseudo Poncet’s

  V. Shobha, A.M. Desai

  46-50

  01-04-2019

  Published: 1 April 2019

  1548

  PDF: 1048
• 

  Sjögren’s syndrome and mean platelet volume

  M. E. Tezcan, Ş. Demir, M. Sargın, M. Aliustaoğlu, B. Göker

  33-34

  30-06-2015

  Published: 30 June 2015

  1300

  PDF: 1073
• 

  A short history of anti-rheumatic therapy - VII. Biological agents

  G. Pasero, P. Marson, B. Gatto

  185-194

  09-11-2011

  Published: 9 November 2011

  1462

  PDF: 1203

• Analysis of the evolution to defined connective tissue diseases of patients with “early unidifferentiated connective tissue diseases (UCTD)”

  M. Mosca, C. Tani, C. Neri, A. Della Rossa, C. Baldini, R. Talarico, L. Carli, S. Bombardieri

  35-40

  Published:

  1785

  PDF: 1514

• HAQ-DI Italian version in systemic sclerosis

  G. La Montagna, G. Cuomo, I. Chiarolanza, L. Ruocco, G. Valentini

  112-115

  Published:

  1494

  PDF: 1912